2003
DOI: 10.1016/s1359-6446(02)02582-5
|View full text |Cite
|
Sign up to set email alerts
|

Pharma-entomology: when bugs become drugs

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
11
0

Year Published

2003
2003
2022
2022

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 23 publications
(11 citation statements)
references
References 8 publications
0
11
0
Order By: Relevance
“…Vol. 60,2003 Review Article even in high concentrations [151]. The cytolytic peptides presented here derive from only a few venomous arthropod species.…”
Section: Discussionmentioning
confidence: 99%
“…Vol. 60,2003 Review Article even in high concentrations [151]. The cytolytic peptides presented here derive from only a few venomous arthropod species.…”
Section: Discussionmentioning
confidence: 99%
“…Insects have been a rich source of antimicrobial peptides, with a cecropin from the moth Hyalophora cecropia (Steiner et al, 1981) being one of the first antimicrobial peptides isolated. Drosophila melanogaster has been extensively studied and is known to produce at least seven different antimicrobial peptides, most in multiple forms (Dimarcq and Hunneyball, 2003).…”
Section: Introductionmentioning
confidence: 99%
“…Thus, most pharmaceutical strategies have been devoted to the development of agents for topical applications, largely because of the relative safety of topical therapy and the uncertainty surrounding the long-term toxicology of any new class of drug administered systemically (15). An approach to controlling unwanted biofilm formation at the surface of implanted materials is to kill the bacteria during their initial attachment rather than trying to remove them once they have adhered.…”
mentioning
confidence: 99%